Mentioned:
Hims & Hers is one of the fastest growing healthcare companies in America. And now, they’re coming after the opportunity in blood testing.
What’s happening:
- Hims & Hers (NASDAQ: HIMS) has announced they have entered into an agreement to acquire at home blood testing startup Trybe Labs
Why it matters:
- This is the first foray Hims & Hers has ever made into blood testing, which has the potential to become a highly lucrative new venture based on the continued growth of new users joining their exceptionally popular telemedicine platform in the United States of America
Going deeper:
- The at home blood testing technology developed by Trybe Labs allows individuals to easily get accurate data on hormone levels, cholesterol, thyroid function and even prostate health
- Hims & Hers has been quickly ramping up revenue through going after the opportunity in weight loss, including both through prescribing GLP-1 drugs as well as previously rolling out a meal subscription business
